Fulgent Genetics, Inc. (FLGT) financial statements and ratios from SEC XBRL: revenue $0.3B (TTM), net margin -18.8%, revenue growth 13.8% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (latest FY) | $322.67M |
| Revenue (TTM) | $0.3B |
| Net Margin | -18.8% |
| Operating Margin (TTM) | -42.6% |
| Revenue Growth (YoY) | 13.8% |
| FCF Growth (YoY) | 545.1% |
| Price / Book | 0.55 |
| Price / Sales | 1.76 |
| FCF Yield | -11.5% |
| Altman Z-Score | 4.59 (safe) |
| Industry P/E (Healthcare Services) | 25.4 |
| Sector P/E (Healthcare) | 21.9 |
FLGT overview · FLGT earnings · FLGT KPIs · FLGT documents · FLGT ownership · FLGT peers
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.